Chuang Cai
Zhongshan, 528445, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Role of claudin-6 in high-grade endometrial carcinoma: Implications for risk stratification and personalized treatment strategies.
Journal: World journal of clinical oncology
Published: November 11, 2025
Age and red cell distribution width in pancreatic cystic neoplasms: A simple tool for preoperative malignancy risk stratification.
Journal: World journal of gastrointestinal surgery
Published: October 09, 2025
Translational artificial intelligence in gastrointestinal and hepatic disorders: Advancing intelligent clinical decision-making for diagnosis, treatment, and prognosis.
Journal: World journal of gastroenterology
Published: June 16, 2025
Neutrophil-to-Lymphocyte Ratio (NLR), Platelet-to-Lymphocyte Ratio (PLR) and Monocyte-to-Lymphocyte Ratio (MLR) as Biomarkers in Diagnosis Evaluation of Acute Exacerbation of Chronic Obstructive Pulmonary Disease: A Retrospective, Observational Study.
Journal: International journal of chronic obstructive pulmonary disease
Published: December 27, 2023
Correction to: Human umbilical cord-derived mesenchymal stem cells protect against experimental colitis via CD5+ B regulatory cells.
Journal: Stem cell research & therapy
Published: January 02, 2019
Mesenchymal Stromal Cells-Derived β2-Microglobulin Promotes Epithelial-Mesenchymal Transition of Esophageal Squamous Cell Carcinoma Cells.
Journal: Scientific reports
Published: December 15, 2017
Stanniocalcin-2 contributes to mesenchymal stromal cells attenuating murine contact hypersensitivity mainly via reducing CD8+ Tc1 cells.
Journal: Cell death & disease
Published: November 22, 2017
CXCR5-Overexpressing Mesenchymal Stromal Cells Exhibit Enhanced Homing and Can Decrease Contact Hypersensitivity.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: September 13, 2016
Human umbilical cord-derived mesenchymal stem cells protect against experimental colitis via CD5(+) B regulatory cells.
Journal: Stem cell research & therapy
Published: May 07, 2016
Showing 1-10 of 10
Last Updated: 09/26/2026